• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PD-1/PD-L1通路与爱泼斯坦-巴尔病毒。

The PD-1/PD-L1 pathway and Epstein-Barr virus.

作者信息

Wang Hui, Zhang Ning, Xu Rongshuang, Ji Cundong, Wei Youzhen, Mi Qing

机构信息

Department of Pediatrics, The Affiliated Taian City Central Hospital of Qingdao University, Taian, Shandong, China.

Department of Emergency, Taian 88 Hospital, Taian, Shandong, China.

出版信息

Eur J Med Res. 2025 Jun 18;30(1):486. doi: 10.1186/s40001-025-02694-1.

DOI:10.1186/s40001-025-02694-1
PMID:40533842
Abstract

Epstein-Barr virus (EBV) is a gamma-herpesvirus with double-stranded DNA. Primary EBV infection leads to infectious mononucleosis (IM) in 20-50% of children and young adults. EBV establishes latent infection in B lymphocytes and can infect T lymphocytes and NK cells, potentially causing lymphoproliferative disorders (LPD) and malignancies. While the PD-1/PD-L1 pathway's role in chronic viral infections is well-established, its specific functions in EBV infection remain poorly understood. Growing evidence suggests this pathway facilitates EBV immune evasion, yet the effect of PD-1 upregulation on Epstein-Barr virus-specific CD8 + T cell function during acute IM is unclear. Furthermore, the role of PD-1/PD-L1 pathway in cytotoxic T cells and immune regulation during EBV infection is still controversial. This review systematically analyzes current knowledge on PD-1/PD-L1 signaling in EBV infection, focusing on three key aspects: (1) its dual role in maintaining immune homeostasis during acute infection while potentially facilitating viral persistence, (2) its emerging potential as a diagnostic biomarker for disease progression and prognosis, particularly during acute infectious mononucleosis, and (3) the therapeutic implications of pathway modulation. We critically evaluate recent advances that position PD-1/PD-L1 at the intersection of virology and tumor immunology, while highlighting important unanswered questions that require further investigation to optimize EBV-specific immunotherapies.

摘要

爱泼斯坦-巴尔病毒(EBV)是一种双链DNA的γ疱疹病毒。原发性EBV感染在20%至50%的儿童和年轻成年人中会导致传染性单核细胞增多症(IM)。EBV在B淋巴细胞中建立潜伏感染,并可感染T淋巴细胞和自然杀伤细胞(NK细胞),有可能导致淋巴增殖性疾病(LPD)和恶性肿瘤。虽然PD-1/PD-L1通路在慢性病毒感染中的作用已得到充分证实,但其在EBV感染中的具体功能仍知之甚少。越来越多的证据表明该通路有助于EBV免疫逃逸,但在急性IM期间PD-1上调对爱泼斯坦-巴尔病毒特异性CD8 + T细胞功能的影响尚不清楚。此外,PD-1/PD-L1通路在EBV感染期间细胞毒性T细胞和免疫调节中的作用仍存在争议。本综述系统分析了当前关于EBV感染中PD-1/PD-L1信号传导的知识,重点关注三个关键方面:(1)其在急性感染期间维持免疫稳态同时可能促进病毒持续存在的双重作用,(2)其作为疾病进展和预后的诊断生物标志物的新潜力,特别是在急性传染性单核细胞增多症期间,以及(3)通路调节的治疗意义。我们批判性地评估了将PD-1/PD-L1置于病毒学和肿瘤免疫学交叉点的最新进展,同时强调了重要的未解决问题,这些问题需要进一步研究以优化EBV特异性免疫疗法。

相似文献

1
The PD-1/PD-L1 pathway and Epstein-Barr virus.PD-1/PD-L1通路与爱泼斯坦-巴尔病毒。
Eur J Med Res. 2025 Jun 18;30(1):486. doi: 10.1186/s40001-025-02694-1.
2
MicroRNA changes with macro potential contribute to secondary immunodeficiency in chronic lymphocytic leukemia during epstein barr virus reactivation.微小RNA变化与宏观潜能共同促成慢性淋巴细胞白血病在爱泼斯坦-巴尔病毒重新激活期间的继发性免疫缺陷。
Sci Rep. 2025 May 12;15(1):16446. doi: 10.1038/s41598-025-01572-4.
3
T cell-mediated immune surveillance conferred by latent Epstein-Barr virus genes suppresses a broad spectrum of tumor formation through NKG2D-NKG2DL interactions.潜伏的爱泼斯坦-巴尔病毒基因赋予的T细胞介导的免疫监视通过NKG2D-NKG2DL相互作用抑制广泛的肿瘤形成。
Front Immunol. 2025 Jun 4;16:1597731. doi: 10.3389/fimmu.2025.1597731. eCollection 2025.
4
The perivascular microenvironment in Epstein-Barr virus positive primary central nervous system lymphoma: The role of programmed cell death 1 and programmed cell death ligand 1.EB 病毒阳性原发性中枢神经系统淋巴瘤的血管周围微环境:程序性细胞死亡 1 和程序性细胞死亡配体 1 的作用。
Neuropathology. 2018 Apr;38(2):125-134. doi: 10.1111/neup.12435. Epub 2017 Oct 24.
5
EBV + B cell-derived exosomes promote EBV-associated T/NK-cell lymphoproliferative disease immune evasion by STAT3/IL-10/PD-L1 pathway.EBV阳性B细胞来源的外泌体通过STAT3/IL-10/PD-L1途径促进EBV相关的T/NK细胞淋巴增殖性疾病的免疫逃逸。
Immunol Res. 2024 Dec;72(6):1327-1336. doi: 10.1007/s12026-024-09531-3. Epub 2024 Aug 20.
6
Clinicopathological evaluation of the programmed cell death 1 (PD1)/programmed cell death-ligand 1 (PD-L1) axis in post-transplant lymphoproliferative disorders: association with Epstein-Barr virus, PD-L1 copy number alterations, and outcome.移植后淋巴组织增生性疾病中程序性细胞死亡蛋白 1(PD1)/程序性细胞死亡配体 1(PD-L1)轴的临床病理评估:与 EBV、PD-L1 拷贝数改变和结局的关联。
Histopathology. 2019 Dec;75(6):799-812. doi: 10.1111/his.13857. Epub 2019 Oct 6.
7
CD8+ T cells retain protective functions despite sustained inhibitory receptor expression during Epstein-Barr virus infection in vivo.CD8+ T 细胞在体内 EBV 感染期间持续表达抑制性受体,但仍保留保护功能。
PLoS Pathog. 2019 May 30;15(5):e1007748. doi: 10.1371/journal.ppat.1007748. eCollection 2019 May.
8
Asymptomatic Primary Infection with Epstein-Barr Virus: Observations on Young Adult Cases.爱泼斯坦-巴尔病毒无症状原发性感染:对年轻成人病例的观察
J Virol. 2017 Oct 13;91(21). doi: 10.1128/JVI.00382-17. Print 2017 Nov 1.
9
Characterization of PD-L1 and PD-1 Expression and CD8+ Tumor-infiltrating Lymphocyte in Epstein-Barr Virus-associated Nasopharyngeal Carcinoma.爱泼斯坦-巴尔病毒相关鼻咽癌中PD-L1和PD-1表达及CD8 +肿瘤浸润淋巴细胞的特征分析
Am J Clin Oncol. 2018 Dec;41(12):1204-1210. doi: 10.1097/COC.0000000000000449.
10
Epstein-Barr Virus-Encoded Latent Membrane Protein 2A Promotes Immune Escape by Upregulating SYK/Nuclear Factor-κB Signaling in Diffuse Large B-cell Lymphoma.爱泼斯坦-巴尔病毒编码的潜伏膜蛋白2A通过上调弥漫性大B细胞淋巴瘤中的SYK/核因子-κB信号促进免疫逃逸。
Lab Invest. 2025 Apr;105(4):104104. doi: 10.1016/j.labinv.2025.104104. Epub 2025 Feb 4.

本文引用的文献

1
Programmed death receptor-1/programmed death-ligand 1 inhibitors: Clinical progress and biomarker exploration in gastric cancer.程序性死亡受体-1/程序性死亡配体1抑制剂:胃癌的临床进展与生物标志物探索
Heliyon. 2024 Oct 4;10(20):e38710. doi: 10.1016/j.heliyon.2024.e38710. eCollection 2024 Oct 30.
2
The diagnostic value of peripheral blood lymphocyte testing in children with infectious mononucleosis.外周血淋巴细胞检测在儿童传染性单核细胞增多症中的诊断价值。
BMC Pediatr. 2024 Nov 16;24(1):746. doi: 10.1186/s12887-024-05228-6.
3
The role of c-Myc in Epstein-Barr virus-associated cancers: Mechanistic insights and therapeutic implications.
c-Myc 在 Epstein-Barr 病毒相关性癌症中的作用:机制见解与治疗意义。
Microb Pathog. 2024 Dec;197:107025. doi: 10.1016/j.micpath.2024.107025. Epub 2024 Oct 18.
4
Analysis of the epidemiology and clinical characteristics of Epstein-Barr virus infection.分析 Epstein-Barr 病毒感染的流行病学和临床特征。
J Med Virol. 2024 Oct;96(10):e29960. doi: 10.1002/jmv.29960.
5
Epstein-Barr virus infection induces tissue-resident memory T cells in mucosal lymphoid tissues.EB 病毒感染诱导黏膜淋巴组织中的组织驻留记忆 T 细胞。
JCI Insight. 2024 Oct 22;9(20):e173489. doi: 10.1172/jci.insight.173489.
6
Evaluation of novel Epstein-Barr virus-derived antigen formulations for monitoring virus-specific T cells in pediatric patients with infectious mononucleosis.评价新型 Epstein-Barr 病毒衍生抗原制剂在监测传染性单核细胞增多症患儿病毒特异性 T 细胞中的作用。
Virol J. 2024 Jun 14;21(1):139. doi: 10.1186/s12985-024-02411-0.
7
PD-1 and PD-L1: architects of immune symphony and immunotherapy breakthroughs in cancer treatment.PD-1 和 PD-L1:免疫交响乐的建筑师和癌症治疗免疫疗法突破的推动者。
Front Immunol. 2023 Dec 1;14:1296341. doi: 10.3389/fimmu.2023.1296341. eCollection 2023.
8
Novel Molecular Therapies and Genetic Landscape in Selected Rare Diseases with Hematologic Manifestations: A Review of the Literature.选定具有血液学表现的罕见疾病中的新型分子疗法和遗传图谱:文献复习。
Cells. 2023 Jan 30;12(3):449. doi: 10.3390/cells12030449.
9
Targeting the PD-1/ PD-L1 interaction in nasopharyngeal carcinoma.针对鼻咽癌中的 PD-1/PD-L1 相互作用。
Oral Oncol. 2021 Feb;113:105127. doi: 10.1016/j.oraloncology.2020.105127. Epub 2021 Jan 14.
10
Clinicopathological analysis of neoplastic PD-L1-positive EBV diffuse large B cell lymphoma, not otherwise specified, in a Japanese cohort.日本队列中肿瘤 PD-L1 阳性 EBV 弥漫性大 B 细胞淋巴瘤,非特指型的临床病理分析。
Virchows Arch. 2021 Mar;478(3):541-552. doi: 10.1007/s00428-020-02901-w. Epub 2020 Aug 15.